Literature DB >> 2314845

Management of encapsulated filtration blebs.

B J Shingleton1, C U Richter, A R Bellows, B T Hutchinson.   

Abstract

Increased intraocular pressure (IOP) in encapsulated filtration blebs was evaluated in 49 eyes of 49 patients followed for 6 to 48 months (mean +/- standard deviation, 19.7 +/- 12.6 months). Intraocular pressure increased from 10.2 +/- 7.5 mmHg at 1 week postfiltration surgery to a peak of 26.1 +/- 10.7 mmHg at 3 weeks postoperatively and then decreased to 16.2 +/- 5.0 mmHg at 16 weeks and remained stable through the follow-up period. Thirty-nine eyes had a final IOP of 19 mmHg or less; 35 eyes required medical therapy alone (antiglaucoma drops, oral carbonic anhydrase inhibitors, and/or digital massage) with a final IOP of 14.1 +/- 3.8 mmHg; and 14 eyes required surgical reintervention for medically uncontrolled IOP elevation, and five of these eyes required two or more surgical reoperative procedures. Vigorous medical therapy, including glaucoma medications, topical steroids, and digital massage, is particularly important for encapsulated blebs during the first 2 months after surgery. After this period, IOP decreases and often remains sufficiently reduced to avoid further surgical intervention.

Entities:  

Mesh:

Year:  1990        PMID: 2314845     DOI: 10.1016/s0161-6420(90)32625-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure.

Authors:  S Lin; D Byles; M Smith
Journal:  Eye (Lond)       Date:  2018-08-29       Impact factor: 3.775

2.  Early transconjunctival needling revision with 5-fluorouracil versus medical treatment in encapsulated blebs: a 12-month prospective study.

Authors:  Ricardo Suzuki; Remo Susanna
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

3.  Revision of trabeculectomy filtering blebs with mitomycin C: Long term results.

Authors:  Maria Tulidowicz-Bielak; Ewa Kosior-Jarecka; Tomasz Żarnowski
Journal:  Indian J Ophthalmol       Date:  2016-11       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.